ET
Eton Pharmaceuticals, Inc.
ETON · NASDAQ
$57.68 -4.53% (-$2.74)
1M -4.57%
Market Cap $1.58B
P/E Ratio 124.53x
Div. Yield -
ROE 40.13%
Bulios Fair Price
$44.83
22.3% downside
Trenutna cena
$57.68
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ETON trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Strong
7/9Valuation
0 /100
Expensive EV/EBITDA 85.23x
P/S 14.96x
P/B 33.92x
Growth
100 /100
Growing FCF growth 71.14%
Book val. growth 25.99%
Rev. growth 55.53%
Profitability
79 /100
Strong Net margin 12.02%
Op. margin 15.44%
FCF margin 13.95%
Quality
95 /100
Excellent ROE 40.13%
ROA 10.96%
Asset turnover 0.91x
Debt
81 /100
Low Current ratio 1.52x
Int. coverage 5.80x
Net debt/EBITDA 0.12x
Stability
26 /100
Unstable Rev. volatility 41.76%
EPS volatility 208.12%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ETON
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Sean E. Brynjelsen
Employees
44
Headquarters
Deer Park
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report